Scanfil Oyj (LON:0Q59)
10.13
-0.05 (-0.49%)
At close: Jan 8, 2026
Scanfil Oyj Revenue
Scanfil Oyj had revenue of 191.30M EUR in the quarter ending September 30, 2025, with 10.39% growth. This brings the company's revenue in the last twelve months to 798.31M, up 1.24% year-over-year. In the year 2024, Scanfil Oyj had annual revenue of 779.91M, down -13.49%.
Revenue (ttm)
798.31M EUR
Revenue Growth
+1.24%
P/S Ratio
0.82
Revenue / Employee
199.48K EUR
Employees
4,002
Market Cap
572.70M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 779.91M | -121.65M | -13.49% |
| Dec 31, 2023 | 901.56M | 57.81M | 6.85% |
| Dec 31, 2022 | 843.76M | 148.02M | 21.28% |
| Dec 31, 2021 | 695.74M | 100.36M | 16.86% |
| Dec 31, 2020 | 595.37M | 15.92M | 2.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| BAE Systems | 27.41B |